RWB
IHE icon

RMR Wealth Builders’s iShares US Pharmaceuticals ETF IHE Stock Holding History

RMR Wealth Builders’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,374
Closed -$81K – 400
2021
Q1 		$81K Buy
+1,374
New +$82.9K 0.02% 299

Other funds holding IHE

Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
MCM
Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return

RMR Wealth Builders's IHE Position: Q2 2021 in Review

RMR Wealth Builders sold out of iShares US Pharmaceuticals ETF (IHE) in Q2 2021, closing a stake of 1,374 shares — an estimated $81K sold.

RMR Wealth Builders first reported a position in IHE in Q1 2021 and held it in 1 quarter. The position peaked at $81K in Q1 2021. 101 funds tracked by Wall St. Rank hold IHE as of Q2 2021.

  • RMR Wealth Builders reported no remaining iShares US Pharmaceuticals ETF position as of Q2 2021 after selling out during the quarter.
  • RMR Wealth Builders sold 1,374 iShares US Pharmaceuticals ETF shares in Q2 2021, an estimated $81K.
  • RMR Wealth Builders first reported a position in iShares US Pharmaceuticals ETF in Q1 2021 and held it in 1 quarter.
  • RMR Wealth Builders's iShares US Pharmaceuticals ETF position peaked at $81K in Q1 2021.
  • 101 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2021.

Based on RMR Wealth Builders's 13F filing for Q2 2021, filed 16 Aug 2021.